BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23504553)

  • 1. Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk.
    Wang Z; Zhang W
    Tumour Biol; 2013 Jun; 34(3):1421-9. PubMed ID: 23504553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between XRCC3 Thr241Met polymorphism and risk of brain tumors: a meta-analysis.
    Liu J; Zhou Z; Lai T; Yin J
    Tumour Biol; 2014 Feb; 35(2):1083-7. PubMed ID: 24061639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis.
    Xu YH; Gu LP; Sun YJ; Cheng BJ; Lu S
    Tumour Biol; 2013 Apr; 34(2):865-74. PubMed ID: 23300009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls.
    Namazi A; Abedinzadeh M; Nourbaksh P; Neamatzadeh H
    Asian Pac J Cancer Prev; 2015; 16(6):2263-8. PubMed ID: 25824748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk.
    Duan C; Zhang W; Lu J; Wu H; Liu M; Zhu W
    Tumour Biol; 2013 Oct; 34(5):2827-34. PubMed ID: 23824570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The XRCC3 Thr241Met polymorphism influences glioma risk - a meta-analysis.
    Jiang J; Quan XF; Zhang L; Wang YC
    Asian Pac J Cancer Prev; 2013; 14(5):3169-73. PubMed ID: 23803098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population.
    Tian X; Tian Y; Ma P; Sui C; Meng F; Li Y; Fu L; Jiang T; Wang Y; Jiang Y
    Tumour Biol; 2013 Oct; 34(5):2589-97. PubMed ID: 23749486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XRCC3 Thr241Met is associated with response to platinum-based chemotherapy but not survival in advanced non-small cell lung cancer.
    Qiu M; Xu L; Yang X; Ding X; Hu J; Jiang F; Xu L; Yin R
    PLoS One; 2013; 8(10):e77005. PubMed ID: 24116196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysis.
    Yan Y; Liang H; Li T; Guo S; Li M; Qin X; Li S
    Leuk Lymphoma; 2014 Sep; 55(9):2130-4. PubMed ID: 24304418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of XRCC3 Thr241Met polymorphisms and gliomas risk: evidence from a meta-analysis.
    Liang HJ; Yan YL; Liu ZM; Chen X; Peng QL; Wang J; Mo CJ; Sui JZ; Wu JR; Zhai LM; Yang S; Li TJ; Li RL; Li S; Qin X
    Asian Pac J Cancer Prev; 2013; 14(7):4243-7. PubMed ID: 23991984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair gene XRCC3 Thr241Met polymorphisms and lung cancer risk: a meta-analysis.
    Bei L; Xiao-Dong T; Yu-Fang G; Jian-Ping S; Zhao-Yu Y
    Bull Cancer; 2015 Apr; 102(4):332-9. PubMed ID: 25794597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between XRCC3 Thr241Met polymorphism and risk of gynecological malignancies: A meta-analysis.
    Yu X; Wang Q; He G; Yu H
    Cancer Genet; 2021 Jun; 254-255():11-17. PubMed ID: 33515810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis.
    Yan Y; Liang H; Li R; Xie L; Li M; Li S; Qin X
    Tumour Biol; 2014 Mar; 35(3):2711-5. PubMed ID: 24254304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XRCC3 Thr241Met polymorphism and clinical outcomes of NSCLC patients receiving platinum-based chemotherapy: a systematic review and meta-analysis.
    Shen XY; Lu FZ; Wu Y; Zhao LT; Lin ZF
    PLoS One; 2013; 8(8):e69553. PubMed ID: 23940523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between XRCC3 Thr241Met Polymorphism and Risk of Breast Cancer: Meta-Analysis of 23 Case-Control Studies.
    Chai F; Liang Y; Chen L; Zhang F; Jiang J
    Med Sci Monit; 2015 Oct; 21():3231-40. PubMed ID: 26498491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the XRCC3 Thr241Met Polymorphism and Gastrointestinal Cancer Risk: A Meta-Analysis.
    Sahami-Fard MH; Mousa Mayali AR; Tajehmiri A
    Asian Pac J Cancer Prev; 2016 Oct; 17(10):4599-4608. PubMed ID: 27892671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XRCC3 Thr241Met polymorphism and gastric cancer susceptibility: a meta-analysis.
    Qin XP; Zhou Y; Chen Y; Li NN; Wu XT
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):226-34. PubMed ID: 24315014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the XRCC3 Thr241Met polymorphism and breast cancer risk: an updated meta-analysis of 36 case-control studies.
    Mao CF; Qian WY; Wu JZ; Sun DW; Tang JH
    Asian Pac J Cancer Prev; 2014; 15(16):6613-8. PubMed ID: 25169497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive effect of XRCC3 Thr241Met polymorphism on platinum-based chemotherapy in lung cancer patients: meta-analysis.
    Zhang W; Yan B; Jiang L
    Tumour Biol; 2013 Dec; 34(6):3989-93. PubMed ID: 23990458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnicity-stratified analysis of the association between XRCC3 Thr241Met polymorphism and leukemia: an updated meta-analysis.
    Xie Z; Peng W; Li Q; Cheng W; Zhao X
    BMC Med Genomics; 2021 Sep; 14(1):229. PubMed ID: 34537044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.